In the UK, all pregnant women are offered screening for Down's syndrome (trisomy 21), Edwards' syndrome (trisomy 18) and Patau's syndrome (trisomy 13). Screening is a personal choice: some parents want as much information as possible, and others prefer not to have it.
This guide explains what the three conditions are, the tests available in the first trimester, how results are reported and what happens if the result shows a higher chance.
Key points
- Screening estimates the chance of Down's, Edwards' and Patau's syndromes; it does not give a diagnosis.
- The NHS combined test (NT, PAPP-A, free β-hCG and your age) detects around 85% of babies with Down's syndrome.
- NIPT is a more accurate screening blood test, available from 10 weeks.
- Only a diagnostic test, such as CVS or amniocentesis, can confirm whether your baby has a chromosomal condition.
What are Down's, Edwards' and Patau's syndromes?
These conditions are caused by an extra copy of a chromosome in the baby's cells.
- Down's syndrome (trisomy 21) causes a varying degree of learning disability, which can range from mild to severe, and can be associated with heart and other health problems. Some pregnancies affected by Down's syndrome end in miscarriage or stillbirth, but many people with Down's syndrome live long lives, with a life expectancy of around 50–60 years.
- Edwards' syndrome (trisomy 18) and Patau's syndrome (trisomy 13) are less common than Down's syndrome and more serious. Many pregnancies end in a loss, either during pregnancy or shortly after birth, and babies usually have major abnormalities or serious health conditions.
The chance of all three conditions rises with the mother's age, but babies with these conditions are born to mothers of all ages.
Combined screening
Combined screening is the standard first-trimester test offered by the NHS. It brings together your age, the nuchal translucency measurement and two blood markers, PAPP-A and free β-hCG, to calculate an individual chance for each condition.
How accurate is it?
According to national screening performance data, the NHS combined test identifies approximately 85% of pregnancies affected by Down's syndrome. This means that around 15% of affected pregnancies receive a lower-chance result despite the condition being present; these are known as false-negative results.
How additional markers improve screening
Screening performance can be improved by a more comprehensive ultrasound assessment. Alongside an accurate NT measurement, a specialist scan can examine the baby's nasal bone, blood flow through the ductus venosus and blood flow across the tricuspid valve. Research from the Fetal Medicine Foundation has shown that including these markers in validated algorithms improves the detection of Down's syndrome while reducing the number of unaffected pregnancies classified as higher chance.
A detailed examination of the baby's anatomy adds further information, because some major abnormalities associated with chromosomal conditions are already visible at 12–13 weeks. No screening approach, however, can identify every affected pregnancy.
For further information, read: Nuchal Translucency (NT): What Is Normal and What Does It Mean?
NIPT
Non-invasive prenatal testing (NIPT) analyses fragments of DNA from the placenta that circulate in your blood. It detects around 99–99.7% of babies with Down's syndrome, with a false-positive rate of around 1 in 1,000, and can be performed from 10 weeks.
In the NHS, NIPT is offered as a second-stage test after a higher-chance combined result. Privately, many parents choose it as their first screening test.
For further information, read: NIPT vs Combined Screening: Which Test Should I Choose?
Detection of Down's syndrome by screening test
Approximate percentage of pregnancies with Down's syndrome identified by each test
Understanding your result
Your result is given as a chance, for example 1 in 2,500. This means that of 2,500 women with the same result, one would have a baby with the condition and 2,499 would not.
- Lower chance: in the NHS, a chance lower than 1 in 150 is reported as lower chance. Most women receive this result.
- Higher chance: a chance of 1 in 150 or greater. Most babies in this group do not have the condition, but further testing is offered.
In private practice, we discuss your individual chance rather than relying only on a single cut-off, so that you can decide what is right for you.
What happens if the chance is higher?
A higher-chance result can be worrying, but it is not a diagnosis. Your options include:
- NIPT, a more accurate screening test with no risk to the pregnancy.
- A diagnostic test, either chorionic villus sampling (CVS) from 11 weeks or amniocentesis from 15 weeks, which gives a definite answer.
- No further testing, if that is your choice.
Your consultant will also review the scan carefully, because a detailed early anatomy assessment can add important information.
For further information, read: Chorionic Villus Sampling (CVS): Procedure, Risks and Results
Is screening right for me?
Screening is optional. Before deciding, it can help to think about what you would do with the information and how you would feel about the possibility of further tests. Whichever path you choose, a detailed scan at 11 to 14 weeks and at 20 to 22 weeks is valuable for checking your baby's development.
Related pregnancy guides
Frequently asked questions
When is first-trimester screening done?
Combined screening is done between 11 weeks 2 days and 14 weeks 1 day. NIPT can be performed from 10 weeks.
How accurate is the combined test?
The NHS combined test identifies around 85% of pregnancies affected by Down's syndrome, so around 15% of affected pregnancies receive a lower-chance result. Adding further ultrasound markers in a specialist assessment can improve performance.
What does a 1 in 150 result mean?
It means that of 150 women with the same result, one would have a baby with the condition. In the NHS, 1 in 150 or greater is reported as higher chance.
Is a higher-chance result a diagnosis?
No. Most babies in the higher-chance group do not have the condition. A diagnostic test such as CVS or amniocentesis is needed to confirm it.
Does screening carry any risk to the baby?
No. Combined screening and NIPT use an ultrasound scan and a blood sample from you, with no risk to the pregnancy. Only diagnostic tests carry a small risk.
Can I choose not to have screening?
Yes. Screening is entirely your choice. You can still have scans to check your baby's development.
Screening at The Pregnancy Clinic
At The Pregnancy Clinic, combined screening and NIPT are offered with a consultant-led nuchal scan and detailed early anatomy assessment. Combined screening results are available within 24 working hours.
If your result shows a higher chance, a fetal medicine specialist will explain it and discuss your options with you, including NIPT and diagnostic testing.
Book a nuchal scan with screening →The Pregnancy Clinic provides planned appointments only. If you have pain, bleeding or any other urgent concern, please contact your local NHS maternity unit, Early Pregnancy Unit, NHS 111 or your GP.
Clinical references
- NHS England. Fetal Anomaly Screening Programme: Screening for Down's, Edwards' and Patau's syndromes.
- NHS England. Fetal Anomaly Screening Programme: Data and screening performance.
- Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004;191:45–67.
- RCOG — Amniocentesis and chorionic villus sampling (Green-top Guideline No. 8)